(No ratings)
Dr. Kenneth Sung-Man Chen, MD is a medical oncologist in Dallas, TX specializing in medical oncology, pediatric oncology, general pediatrics and general practice. He graduated from University of Texas Southwestern Medical School in 2006 and has 18 years of experience. Dr. Kenneth Sung-Man Chen, MD is affiliated with Children's Health (Texas), Children's Health System, UT Southwestern Medical Center and Children’s Medical Center Dallas.
1935 Medical District Drive Suite C6403
Dallas, TX 75235
Dr. Kenneth Sung-Man Chen, MD graduated from University of Texas Southwestern Medical School in 2006. He completed residency at UT Southwestern - Children's Medical Center. He is certified by the American Board of Pediatrics/Hematology-Oncology and has a state license in Texas.
Medical School: University of Texas Southwestern Medical School (2006)
Residency: UT Southwestern - Children's Medical Center (2009)
Board Certification: American Board of Pediatrics/Hematology-Oncology
Licensed In: Texas
Dr. Kenneth Sung-Man Chen, MD is associated with these hospitals and organizations:
Dr. Kenneth Sung-Man Chen, MD does not have any reviews yet, be the first to leave a review of Dr. Kenneth Sung-Man Chen, MD here: Leave a Review
(No ratings)
Dr. Kenneth Chen's areas of specialization are general practice, pediatric hematology/oncology, and medical oncology; he sees patients in Dallas, TX. These areas are among his clinical interests: leukemia, germ cell tumors, and hepatoblastoma. After completing medical school at the University of Texas Southwestern Medical School, he performed his residency at a hospital affiliated with the University of Texas Southwestern Medical Center at Dallas. Dr. Chen has received distinctions including Texas Monthly Super Doctors, Rising Star; W.W. Caruth Scholar; and Children s Medical Center Foundation Damon Runyon-Sohn Pediatric Cancer Fellow. He is affiliated with Children's Health (Texas) and UT Southwestern Medical Center. He welcomes new patients at his office inDallas, TX as reported by Yext.